Es una suerte contar con una organización como @saludporderecho.bsky.socialsaludporderecho.org/lenacapavir-...

Lenacapavir: las licencias voluntarias de Gilead no llegan a países que las necesitan

El pasado 2 de octubre, Gilead anunció la firma de acuerdos de licencias voluntarias con seis compañías para la producción y suministro de genéricos de lenacapavir. Estos acuerdos llegan tras

Gilead’s Lenacapavir, a 2x/year injection, offers almost complete protection against HIV. A new deal makes it available in 120 low-middle income countries, but the deal abandons many Latin American and lacks transparency over pricing. Credit: Tulio de Oliveira. www.theguardian.com/global-devel...

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highest

EVA Pharma Signs a Voluntary Licensing Agreement with #Gilead#Lenacapavir#HIV) Incidence and Limited Resources […]

IAC kirim banding guna batalkan paten Gilead atas obat HIV Lenacapavir - https://www.antaranews.com/berita/4376278/iac-kirim-banding-guna-batalkan-paten-gilead-atas-obat-hiv-lenacapavir

'In this randomized, controlled trial involving women in South Africa and Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection.' www.nejm.org

El lenacapavir, administrado en forma de inyección dos veces al año, ha demostrado tener buenos resultados en la prevención del VIH. Detuvo la infección en un ensayo en el que participaron niñas y mujeres de Sudáfrica y Uganda, y ofreció una protección casi completa en un segundo ensayo...

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highest

Medicamento de prevenção do HIV ‘Gamechanger’ será disponibilizado a baixo custo em 120 países Gilead Sciences anuncia acordo para fabricar versões genéricas do lenacapavir, mas críticos dizem que ele exclui muitos países onde a incidência é mais alta www.theguardian.com/global-devel...

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highest

🚨ATENÇÃO: Brasil fica fora do acordo que permite a produção da versão genérica da vacina contra o HIV. A empresa não mencionou quanto custará o lenacapavir quando usado para prevenir infecções por HIV, um processo chamado de profilaxia pré-exposição, ou PrEP.

This is a huge step forward toward access for the most vulnerable and I’m thrilled it’s happened so quickly. But still glad the International AIDS society is continuing to push for universal access.

Six generic pharmas "will be permitted to sell the drug in 120 countries, including all the countries with the highest rates of H.I.V., which are in sub-Saharan Africa." https://www.nytimes.com/2024/10/02/health/lenacapavir-hiv-shot-prep.html

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.